Expression of NANOG in human gliomas and its relationship with undifferentiated glioma cells

Oncology Reports

Volumn 26, Issue 3, 2011, Pages 593-601

  Niu, Chao Shi ^a,b   Li, Dong Xue ^a,b   Liu, Yu Hai ^a,b   Fu, Xian Ming ^a,b   Tang, Shen Feng ^b   Li, Jing ^b  

^a ANHUI MEDICAL UNIVERSITY   (China)

^b Anhui Provincial Stereotactic Neurosurgical Institute   (China)

Author keywords

Differentiation; Expression; Glioma; NANOG

Indexed keywords

CD133 ANTIGEN; MESSENGER RNA; TRANSCRIPTION FACTOR NANOG;

ADULT; ARTICLE; CANCER PATIENT; CARCINOGENESIS; CONTROLLED STUDY; GLIOMA; GLIOMA CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; UNDIFFERENTIATED CARCINOMA;

ANTIGENS, CD; BRAIN NEOPLASMS; CELL ADHESION; CELL LINE, TUMOR; CELL NUCLEUS; GENE EXPRESSION; GLIAL FIBRILLARY ACIDIC PROTEIN; GLIOMA; GLYCOPROTEINS; HOMEODOMAIN PROTEINS; HUMANS; NEOPLASTIC STEM CELLS; PEPTIDES; TUMOR MARKERS, BIOLOGICAL;

EID: 79959973296     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2011.1308     Document Type: Article

References (38)

1. Huntly BJ and Gilliland DG: Cancer biology: summing up cancer stem cells. Nature 435: 1169-1170, 2005. (Pubitemid 40943069)
2. Singh SK, Clarke ID, Terasaki M, et al: Identification of a cancer stem cell in human brain tumors. Cancer Res 63: 5821-5828, 2003. (Pubitemid 37187480)
3. Bertrand J, Begaud-Grimaud G, Bessette B, Verdier M, Battu S and Jauberteau MO: Cancer stem cells from human glioma cell line are resistant to Fas-induced apoptosis. Int J Oncol 34: 717-727, 2009.
4. Li GH, Chen ZT, Hu YD, et al: Autocrine factors sustain glioblastoma stem cell self-renewal. Oncol Rep 21: 419-424, 2009.
5. Du Z, Jia D, Liu S, et al: Oct4 is expressed in human gliomas and promotes colony formation in glioma cells. Glia 57 724-733, 2009.
6. Mitsui K, Tokuzawa Y, Itoh H, et al: The homeoprotein Nanog is required for maintenance of pluripotency in mouse epiblast and ES cells. Cell 113: 631-642, 2003. (Pubitemid 36694188)
7. Chambers I, Colby D, Robertson M, et al: Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells. Cell 113: 643-655, 2003. (Pubitemid 36694189)
8. Hart AH, Hartley L, Ibrahim M and Robb L: Identification, cloning and expression analysis of the pluripotency promoting Nanog genes in mouse and human. Dev Dyn 230: 187-198, 2004. (Pubitemid 38544086)
9. Boyer LA, Lee TI, Cole MF, et al: Core transcriptional regulatory circuitry in human embryonic stem cells. Cell 122: 947-956, 2005. (Pubitemid 41345211)
10. Darr H, Mayshar Y and Benvenisty N: Overexpression of NANOG in human ES cells enables feeder-free growth while inducing primitive ectoderm features. Development 133: 1193-1201, 2006.
11. Takahashi K and Yamanaka S: Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126: 663-676, 2006. (Pubitemid 44233629)
12. Yu J, Vodyanik MA, Smuga-Otto K, et al: Induced pluripotent stem cell lines derived from human somatic cells. Science 318: 1917-1920, 2007.
13. Almstrup K, Hoei-Hansen CE, Wirkner U, et al: Embryonic stem cell-like features of testicular carcinoma in situ revealed by genome-wide gene expression profiling. Cancer Res 64: 4736-4743, 2004. (Pubitemid 38924515)
14. You JS, Kang JK, Seo DW, et al: Depletion of embryonic stem cell signature by histone deacetylase inhibitor in NCCIT cells: involvement of Nanog suppression. Cancer Res 69: 5716-5725, 2009.
15. Hart AH, Hartley L, Parker K, et al: The pluripotency homeobox gene NANOG is expressed in human germ cell tumors. Cancer 104: 2092-2098, 2005. (Pubitemid 41579954)
16. Fujii H, Honoki K, Tsujiuchi T, Kido A, Yoshitani K and Takakura Y: Sphere-forming stem-like cell populations with drug resistance in human sarcoma cell lines. Int J Oncol 34: 1381-1386, 2009.
17. Ye F, Zhou C, Cheng Q, Shen J and Chen H: Stem-cell-abundant proteins Nanog, Nucleostemin and Musashil are highly expressed in malignant cervical epithelial cells. BMC Cancer 8: 108, 2008.
18. Ezeh UI, Turek PJ, Reijo RA and Clark AT: Human embryonic stem cell genes OCT4, NANOG, STELLAR, and GDF3 are expressed in both seminoma and breast carcinoma. Cancer 104: 2255-2265, 2005. (Pubitemid 41579973)
19. Alldridge L, Metodieva G, Greenwood C, et al: Proteome profiling of breast tumors by gel electrophoresis and nanoscale electrospray ionization mass spectrometry. J Proteome Res 7: 1458-1469, 2008.
20. Chiou SH, Yu CC, Huang CY, et al: Positive correlations of Oct-4 and Nanog in oral cancer stem-like cells and high-grade oral squamous cell carcinoma. Clin Cancer Res 14: 4085-4095, 2008.
21. Bussolati B, Bruno S, Grange C, Ferrando U and Camussi G: Identification of a tumor-initiating stem cell population in human renal carcinomas. FASEB J 22: 3696-3705, 2008.
22. Zhang S, Balch C, Chan MW, et al: Identification and characterization of ovarian cancer-initiating cells from primary human tumors. Cancer Res 68: 4311-4320, 2008.
23. Jeter CR, Badeaux M, Choy G, et al: Functional evidence that the self-renewal gene NANOG regulates human tumor development. Stem Cells 27: 993-1005, 2009.
24. Wang L, Park P and Lin CY: Characterization of stem cell attributes in human osteosarcoma cell lines. Cancer Biol Ther 8: 543-552, 2009.
25. Santagata S, Hornick JL and Ligon KL: Comparative analysis of germ cell transcription factors in CNS germinoma reveals diagnostic utility of NANOG. Am J Surg Pathol 30: 1613-1618, 2006. (Pubitemid 44808799)
26. Ben-Porath I, Thomson MW, Carey VJ, et al: An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors. Nat Genet 40: 499-507, 2008. (Pubitemid 351601215)
27. Zbinden M, Duquet A, Lorente-Trigos A, Ngwabyt SN, Borges I and Ruiz i Altaba A: NANOG regulates glioma stem cells and is essential in vivo acting in a cross-functional network with GLI1 and p53. EMBO J 29: 2475-2476, 2010.
28. Kong DS, Kim MH, Park WY, et al: The progression of gliomas is associated with cancer stem cell phenotype. Oncol Rep 19: 639-643, 2008. (Pubitemid 351330429)
29. Gangemi RM, Griffero F, Marubbi D, et al: SOX2 silencing in glioblastoma tumor-initiating cells causes stop of proliferation and loss of tumorigenicity. Stem Cells 27: 40-48, 2009.
30. Lapidot T, Sirard C, Vormoor J, et al: A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature 367: 645-648, 1994. (Pubitemid 24067706)
31. Wicha MS, Liu S and Dontu G: Cancer stem cells: an old idea - a paradigm shift. Cancer Res 66: 1883-1890, 2006.
32. Singh SK, Clarke ID, Hide T and Dirks PB: Cancer stem cells in nervous system tumors. Oncogene 23: 7267-7273, 2004. (Pubitemid 39382160)
33. Li GH, Wei H, Lv SQ, Ji H and Wang DL: Knockdown of STAT3 expression by RNAi suppresses growth and induces apoptosis and differentiation in glioblastoma stem cells. Int J Oncol 37: 103-110, 2010.
34. Niwa H, Ogawa K, Shimosato D and Adachi K: A parallel circuit of LIF signalling pathways maintains pluripotency of mouse ES cells. Nature 460: 118-122, 2009.
35. Silva J, Nichols J, Theunissen TW, et al: Nanog is the gateway to the pluripotent ground state. Cell 138: 722-737, 2009.
36. Hirschmann-Jax C, Foster AE, Wulf GG, et al: A distinct 'side population' of cells with high drug efflux capacity in human tumor cells. Proc Natl Acad Sci USA 101: 14228-14233, 2004.
37. Kang SK, Park JB and Cha SH: Multipotent, dedifferentiated cancer stem-like cells from brain gliomas. Stem Cell Dev 15: 423-435, 2006. (Pubitemid 44100018)
38. - metastatic colon cancer cells initiate tumors. J Clin Invest 118: 2111-2120, 2008. (Pubitemid 351872330)